_________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
Explore our resources designed to provide useful information on ENTRESTO and support with initiation and ongoing treatment.
You can download certain files below for you to share with your patients separately. In order to view these files, you will be required to register. Please do not share links to this website or screenshots with patients, as this website is intended for UK healthcare professionals only. Some materials are also available in hard copy and can be requested below.
HCP’s guide to MyEntresto & YourChoice Engage
Request a copy for our introductory guide to MyEntresto & YourChoice Engage: our online patient resource designed to support you in empowering your patients to stay on top of their condition and treatment, with the aim of improving adherence. This outlines the key features of the platform, and how these can support your patients.
ENTRESTO patient profiles
Download our patient case study resource to learn how ENTRESTO can reduce the burden of heart failure and improve the quality of life in patients diagnosed with HFrEF.
Prescribe with confidence
Download our ENTRESTO prescribing guidance leave piece, which includes information on recommended dosing, safety profile and dosing considerations.
Start with ENTRESTO
Download our guide to starting treatment with ENTRESTO, which summarises the data from key clinical trials and highlights the recommendations from the CaReMe UK Partnership, ACC, and ESC.
ENTRESTO clinical trials
Download our leave piece to learn more about the study design, efficacy and safety data from five key ENTRESTO clinical trials.
Cardiologist infographic
Download our step-by-step guide, which has been designed to highlight how ENTRESTO can help you better manage your patients with HFrEF upon hospital admission.
Patient Outcomes and Successes
Download our leave piece outlining the data supporting quality of life benefits your patients could experience while on ENTRESTO vs ACEi (enalapril).
Top tips for reviewing patients with chronic heart failure in a virtual consultation
Download this infographic, which is designed to give you top tips on how to get the most out of your virtual consultations with your adult patients who have been diagnosed with chronic HFrEF.
Northern Health and Social Care Trust ENTRESTO initiation checklist
Review this initiation checklist, independently developed by the Northern Health and Social Care Trust, which outlines practical considerations for the initiation, management and dose adjustment of ENTRESTO for inpatients.
George Eliot Hospital initiation checklist
Review this initiation checklist, independently developed by the George Eliot Hospital Trust, which also outlines practical considerations for the initiation, management and dose adjustment of ENTRESTO for inpatients.
NHS Lothian Heart Failure Protocol
Download the Standard Drug Optimisation Protocol developed by the NHS Lothian Heart Failure Team, to learn about the optimisation strategy for the four medicines making up the cornerstone therapy for treating chronic HFrEF.
CareMe UK Pathway
Download the recently updated CaReMe UK treatment algorithm for patients diagnosed with heart failure whereby ENTRESTO has been recommended as a first line treatment option for eligible chronic HFrEF patients.
Bradford Affinity Care HF pathway
Download the Affinity Care heart failure pathway to better understand how to detect, diagnose, and manage your HF patients.
Treatment Algorithm for Guideline-Directed Medical Therapy Including Novel Therapies
Download the treatment algorithm developed by the ACC, which includes guidelines on initiating therapies to treat and manage a HFrEF diagnosis in your patients. You can also read the updated paper issued by the ACC in the following journal article: Maddox TM, et al. J Am Coll Cardiol 2021;77:772–810.
Inpatient discharge letter template
Request a copy of an impatient letter template for you complete and hand over to your patient having been initiated on ENTRESTO. This letter is aimed at their primary care team, providing the rationale for ENTRESTO initiation, alongside guidance on managing the patient and treatment within the community.
Outpatient discharge letter template
Request a copy of an outpatient discharge letter template for you to complete and handover to your patient having on ENTRESTO. This letter is aimed at their primary care team, providing the rationale for ENTRESTO initiation, alongside guidance on managing the patient and treatment within the community.
Your guide to ENTRESTO
Download our guide to treatment with ENTRESTO, outlining what to expect from this medicine, as well as hints and tips on managing your treatment.
Your in-hospital guide to ENTRESTO
This guide is for patients whom you have initiated on ENTRESTO as an inpatient. It also outlines what to expect from their treatment, as well as hints and tips on managing it upon their return home.
MyEntresto and YourChoice Engage
This guide introduces the MyEntresto website, as well as the opt-in email communication programme designed for patients prescribed ENTRESTO. Both are aimed at supporting your patients along their treatment journey with ENTRESTO, to take ownership of managing their treatment and condition, to help improve adherence.
MyEntresto patient website
Explore MyEntresto: our post-prescription patient website designed to support your patients with managing their condition and treatment, as well as possible side effects, in addition to useful hints and tips to support them with living with heart failure. Please note this is a non-promotional Novartis website that will open outside of this website.
Expert opinion on the implications of the British Society for Heart Failure position statement on Non-Medical Prescribing of Specialist Initiation Medicines in Heart Failure
Watch our expert speaker Dr Stephen Pettit, Consultant Cardiologist at Royal Papworth Hospital, give his perspective on the position statement, discussing what it captures and how it may impact practice.
Further resources for nurses:
HCP’s guide to MyEntresto & YourChoice Engage
Request a copy for our introductory guide to MyEntresto & YourChoice Engage: our online patient resource designed to support you in empowering your patients to stay on top of their condition and treatment, with the aim of improving adherence. This outlines the key features of the platform, and how these can support your patients.
British Society for Heart Failure (BSH) Statement
Download a statement from the BSH which highlights their held position on non-medical prescribing of specialist initiation medicines in cases of patients with heart failure.
Top tips for heart failure specialist nurses
This infographic aimed at heart failure specialist nurses (HFSNs) provides top tips for reviewing patients with chronic heart failure in a virtual consultation.
Resources for nurses: The Heart to Heart podcast series
Listen to our podcast series made specifically to provide support to heart failure specialist nurses who are facing particular challenges in their current practice. Discussion topics include the role of a HFSN, how guidelines can help empower you with prescribing ENTRESTO, the importance of early patient identification, effective patient management across primary, secondary and community services, and as well as psychological support for your patients.
Access our comprehensive on-demand webinars collection to further your learning here
Indication: ENTRESTO® is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.1
ACC, American College of Cardiology; ACEi, angiotensin-converting enzyme inhibitor; ECC, European Society of Cardiology; HF, heart failure; HFrEF, heart failure with reduced ejection fraction; HFSN, heart failure specialist nurse.
Reference
- ENTRESTO® Summary of Product Characteristics, 2021.